Clinical trial
Efficacy and Safety of Burosumab Versus Oral Phosphate and Active Vitamin D…
NCT02915705 · Kyowa Kirin, Inc., Industry · Completed
Key facts
| NCT number | NCT02915705 |
|---|---|
| Title | Efficacy and Safety of Burosumab Versus Oral Phosphate and Active Vitamin D Treatment in Pediatric Patients With XLH |
| Official title | A Randomized, Open-Label, Phase 3 Study to Assess the Efficacy and Safety of KRN23 Versus Oral Phosphate and Active Vitamin D Treatment in Pediatric Patients With X Linked Hypophosphatemia (XLH) |
| Lead sponsor | Kyowa Kirin, Inc., Industry |
| Collaborators | Kyowa Kirin Co., Ltd. Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | X-Linked Hypophosphatemia |
| Intervention type | Biological, Drug |
| Interventions | burosumab, Oral Phosphate Supplement, active vitamin D |
| Enrollment | 61 |
| Start date | Sep 8, 2016 |
| Primary completion | Feb 12, 2018 |
| Completion | Jul 15, 2019 |
| First posted | Sep 27, 2016 |
| Last update posted | Aug 29, 2024 |
| Countries | Australia, Canada, Japan, South Korea, Sweden, United Kingdom, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: